Loading…
Bioactive lipids in gintonin-enriched fraction from ginseng
Ginseng is a traditional herbal medicine for human health. Ginseng contains a bioactive ligand named gintonin. The active ingredient of gintonin is lysophosphatidic acid C18:2 (LPA C18:2). We previously developed a method for gintonin-enriched fraction (GEF) preparation to mass-produce gintonin from...
Saved in:
Published in: | Journal of ginseng research 2019, 43(2), , pp.209-217 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243 |
---|---|
cites | cdi_FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243 |
container_end_page | 217 |
container_issue | 2 |
container_start_page | 209 |
container_title | Journal of ginseng research |
container_volume | 43 |
creator | Cho, Hee-Jung Choi, Sun-Hye Kim, Hyeon-Joong Lee, Byung-Hwan Rhim, Hyewon Kim, Hyoung-Chun Hwang, Sung-Hee Nah, Seung-Yeol |
description | Ginseng is a traditional herbal medicine for human health. Ginseng contains a bioactive ligand named gintonin. The active ingredient of gintonin is lysophosphatidic acid C18:2 (LPA C18:2). We previously developed a method for gintonin-enriched fraction (GEF) preparation to mass-produce gintonin from ginseng. However, previous studies did not show the presence of other bioactive lipids besides LPAs. The aim of this study was to quantify the fatty acids, lysophospholipids (LPLs), and phospholipids (PLs) besides LPAs in GEF.
We prepared GEF from white ginseng. We used gas chromatography-mass spectrometry for fatty acid analysis and liquid chromatography-tandem mass spectrometry for PL analysis, and quantified the fatty acids, LPLs, and PLs in GEF using respective standards. We examined the effect of GEF on insulin secretion in INS-1 cells.
GEF contains about 7.5% linoleic (C18:2), 2.8% palmitic (C16:0), and 1.5% oleic acids (C18:1). GEF contains about 0.2% LPA C18:2, 0.06% LPA C16:0, and 0.02% LPA C18:1. GEF contains 0.08% lysophosphatidylcholine, 0.03% lysophosphatidylethanolamine, and 0.13% lysophosphatidylinositols. GEF also contains about 1% phosphatidic acid (PA) 16:0-18:2, 0.5% PA 18:2-18:2, and 0.2% PA 16:0-18:1. GEF-mediated insulin secretion was not blocked by LPA receptor antagonist.
We determined four characteristics of GEF through lipid analysis and insulin secretion. First, GEF contains a large amount of linoleic acid (C18:2), PA 16:0-18:2, and LPA C18:2 compared with other lipids. Second, the main fatty acid component of LPLs and PLs is linoleic acid (C18:2). Third, GEF stimulates insulin secretion not through LPA receptors. Finally, GEF contains bioactive lipids besides LPAs. |
doi_str_mv | 10.1016/j.jgr.2017.11.006 |
format | article |
fullrecord | <record><control><sourceid>nurimedia_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_4845096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><nurid>NODE08758665</nurid><els_id>S1226845317302981</els_id><doaj_id>oai_doaj_org_article_ce3df733218c4fd0b131ff6b8f47dc4d</doaj_id><sourcerecordid>NODE08758665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EotvCB-CC9sKBQ4Id_40qIZW2wEoVlVA5W157nDrdtVdOuhLfHmdTVvTCaSzP7z2P5yH0juCaYCI-9XXf5brBRNaE1BiLF2jR4JZWrGXyJVqQphGVYpyeoNNh6AsgG8leoxOKW9FIyhfo_EtIxo5hD8tN2AU3LENcdiGOKYZYQczB3oNb-jxBKZZD2k79AWL3Br3yZjPA26d6hn59vb67_F7d3H5bXV7cVJYrMlbMCs6VlQoL5wURmGPh1xywd9wZkASUc6CEcS2AcwxTbKhVlDa-8A2jZ-jj7Buz1w826GTCoXZJP2R98fNupVn5ZvlUYVcz65Lp9S6Hrcm_D4LDRcqdNnkMdgPaAnVelmeIssw7vCaUeC_WyjPpLHPF6_PstXtcb8FZiGM2m2emzzsx3JeZ9lowKmk7DU5mA5vTMGTwRy3BekpQ97okqKcENSG6BFQ07_999Kj4G1kBPjxt47G0wAVzZH7cXl1jJbkSYuLOZw5KNPsAWQ82QLRFkcGOZR_hP2P8AUg_uZc</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bioactive lipids in gintonin-enriched fraction from ginseng</title><source>ScienceDirect (Online service)</source><source>PubMed Central</source><creator>Cho, Hee-Jung ; Choi, Sun-Hye ; Kim, Hyeon-Joong ; Lee, Byung-Hwan ; Rhim, Hyewon ; Kim, Hyoung-Chun ; Hwang, Sung-Hee ; Nah, Seung-Yeol</creator><creatorcontrib>Cho, Hee-Jung ; Choi, Sun-Hye ; Kim, Hyeon-Joong ; Lee, Byung-Hwan ; Rhim, Hyewon ; Kim, Hyoung-Chun ; Hwang, Sung-Hee ; Nah, Seung-Yeol</creatorcontrib><description>Ginseng is a traditional herbal medicine for human health. Ginseng contains a bioactive ligand named gintonin. The active ingredient of gintonin is lysophosphatidic acid C18:2 (LPA C18:2). We previously developed a method for gintonin-enriched fraction (GEF) preparation to mass-produce gintonin from ginseng. However, previous studies did not show the presence of other bioactive lipids besides LPAs. The aim of this study was to quantify the fatty acids, lysophospholipids (LPLs), and phospholipids (PLs) besides LPAs in GEF.
We prepared GEF from white ginseng. We used gas chromatography-mass spectrometry for fatty acid analysis and liquid chromatography-tandem mass spectrometry for PL analysis, and quantified the fatty acids, LPLs, and PLs in GEF using respective standards. We examined the effect of GEF on insulin secretion in INS-1 cells.
GEF contains about 7.5% linoleic (C18:2), 2.8% palmitic (C16:0), and 1.5% oleic acids (C18:1). GEF contains about 0.2% LPA C18:2, 0.06% LPA C16:0, and 0.02% LPA C18:1. GEF contains 0.08% lysophosphatidylcholine, 0.03% lysophosphatidylethanolamine, and 0.13% lysophosphatidylinositols. GEF also contains about 1% phosphatidic acid (PA) 16:0-18:2, 0.5% PA 18:2-18:2, and 0.2% PA 16:0-18:1. GEF-mediated insulin secretion was not blocked by LPA receptor antagonist.
We determined four characteristics of GEF through lipid analysis and insulin secretion. First, GEF contains a large amount of linoleic acid (C18:2), PA 16:0-18:2, and LPA C18:2 compared with other lipids. Second, the main fatty acid component of LPLs and PLs is linoleic acid (C18:2). Third, GEF stimulates insulin secretion not through LPA receptors. Finally, GEF contains bioactive lipids besides LPAs.</description><identifier>ISSN: 1226-8453</identifier><identifier>EISSN: 2093-4947</identifier><identifier>DOI: 10.1016/j.jgr.2017.11.006</identifier><identifier>PMID: 30962735</identifier><language>eng</language><publisher>Korea (South): Elsevier B.V</publisher><subject>Ginseng ; Gintonin ; Insulin ; LPA ; Phosphatidic acid ; 기타의약학</subject><ispartof>Journal of Ginseng Research, 2019, 43(2), , pp.209-217</ispartof><rights>2018</rights><rights>2018 The Korean Society of Ginseng, Published by Elsevier Korea LLC. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243</citedby><cites>FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243</cites><orcidid>0000-0003-4257-577X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437394/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1226845317302981$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3547,27923,27924,45779,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30962735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002457734$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Cho, Hee-Jung</creatorcontrib><creatorcontrib>Choi, Sun-Hye</creatorcontrib><creatorcontrib>Kim, Hyeon-Joong</creatorcontrib><creatorcontrib>Lee, Byung-Hwan</creatorcontrib><creatorcontrib>Rhim, Hyewon</creatorcontrib><creatorcontrib>Kim, Hyoung-Chun</creatorcontrib><creatorcontrib>Hwang, Sung-Hee</creatorcontrib><creatorcontrib>Nah, Seung-Yeol</creatorcontrib><title>Bioactive lipids in gintonin-enriched fraction from ginseng</title><title>Journal of ginseng research</title><addtitle>J Ginseng Res</addtitle><description>Ginseng is a traditional herbal medicine for human health. Ginseng contains a bioactive ligand named gintonin. The active ingredient of gintonin is lysophosphatidic acid C18:2 (LPA C18:2). We previously developed a method for gintonin-enriched fraction (GEF) preparation to mass-produce gintonin from ginseng. However, previous studies did not show the presence of other bioactive lipids besides LPAs. The aim of this study was to quantify the fatty acids, lysophospholipids (LPLs), and phospholipids (PLs) besides LPAs in GEF.
We prepared GEF from white ginseng. We used gas chromatography-mass spectrometry for fatty acid analysis and liquid chromatography-tandem mass spectrometry for PL analysis, and quantified the fatty acids, LPLs, and PLs in GEF using respective standards. We examined the effect of GEF on insulin secretion in INS-1 cells.
GEF contains about 7.5% linoleic (C18:2), 2.8% palmitic (C16:0), and 1.5% oleic acids (C18:1). GEF contains about 0.2% LPA C18:2, 0.06% LPA C16:0, and 0.02% LPA C18:1. GEF contains 0.08% lysophosphatidylcholine, 0.03% lysophosphatidylethanolamine, and 0.13% lysophosphatidylinositols. GEF also contains about 1% phosphatidic acid (PA) 16:0-18:2, 0.5% PA 18:2-18:2, and 0.2% PA 16:0-18:1. GEF-mediated insulin secretion was not blocked by LPA receptor antagonist.
We determined four characteristics of GEF through lipid analysis and insulin secretion. First, GEF contains a large amount of linoleic acid (C18:2), PA 16:0-18:2, and LPA C18:2 compared with other lipids. Second, the main fatty acid component of LPLs and PLs is linoleic acid (C18:2). Third, GEF stimulates insulin secretion not through LPA receptors. Finally, GEF contains bioactive lipids besides LPAs.</description><subject>Ginseng</subject><subject>Gintonin</subject><subject>Insulin</subject><subject>LPA</subject><subject>Phosphatidic acid</subject><subject>기타의약학</subject><issn>1226-8453</issn><issn>2093-4947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kU9v1DAQxS0EotvCB-CC9sKBQ4Id_40qIZW2wEoVlVA5W157nDrdtVdOuhLfHmdTVvTCaSzP7z2P5yH0juCaYCI-9XXf5brBRNaE1BiLF2jR4JZWrGXyJVqQphGVYpyeoNNh6AsgG8leoxOKW9FIyhfo_EtIxo5hD8tN2AU3LENcdiGOKYZYQczB3oNb-jxBKZZD2k79AWL3Br3yZjPA26d6hn59vb67_F7d3H5bXV7cVJYrMlbMCs6VlQoL5wURmGPh1xywd9wZkASUc6CEcS2AcwxTbKhVlDa-8A2jZ-jj7Buz1w826GTCoXZJP2R98fNupVn5ZvlUYVcz65Lp9S6Hrcm_D4LDRcqdNnkMdgPaAnVelmeIssw7vCaUeC_WyjPpLHPF6_PstXtcb8FZiGM2m2emzzsx3JeZ9lowKmk7DU5mA5vTMGTwRy3BekpQ97okqKcENSG6BFQ07_999Kj4G1kBPjxt47G0wAVzZH7cXl1jJbkSYuLOZw5KNPsAWQ82QLRFkcGOZR_hP2P8AUg_uZc</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Cho, Hee-Jung</creator><creator>Choi, Sun-Hye</creator><creator>Kim, Hyeon-Joong</creator><creator>Lee, Byung-Hwan</creator><creator>Rhim, Hyewon</creator><creator>Kim, Hyoung-Chun</creator><creator>Hwang, Sung-Hee</creator><creator>Nah, Seung-Yeol</creator><general>Elsevier B.V</general><general>고려인삼학회</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>DBRKI</scope><scope>TDB</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0003-4257-577X</orcidid></search><sort><creationdate>20190401</creationdate><title>Bioactive lipids in gintonin-enriched fraction from ginseng</title><author>Cho, Hee-Jung ; Choi, Sun-Hye ; Kim, Hyeon-Joong ; Lee, Byung-Hwan ; Rhim, Hyewon ; Kim, Hyoung-Chun ; Hwang, Sung-Hee ; Nah, Seung-Yeol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Ginseng</topic><topic>Gintonin</topic><topic>Insulin</topic><topic>LPA</topic><topic>Phosphatidic acid</topic><topic>기타의약학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cho, Hee-Jung</creatorcontrib><creatorcontrib>Choi, Sun-Hye</creatorcontrib><creatorcontrib>Kim, Hyeon-Joong</creatorcontrib><creatorcontrib>Lee, Byung-Hwan</creatorcontrib><creatorcontrib>Rhim, Hyewon</creatorcontrib><creatorcontrib>Kim, Hyoung-Chun</creatorcontrib><creatorcontrib>Hwang, Sung-Hee</creatorcontrib><creatorcontrib>Nah, Seung-Yeol</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>DBPIA - 디비피아</collection><collection>DBPIA (누리미디어)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><collection>Korean Citation Index</collection><jtitle>Journal of ginseng research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cho, Hee-Jung</au><au>Choi, Sun-Hye</au><au>Kim, Hyeon-Joong</au><au>Lee, Byung-Hwan</au><au>Rhim, Hyewon</au><au>Kim, Hyoung-Chun</au><au>Hwang, Sung-Hee</au><au>Nah, Seung-Yeol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioactive lipids in gintonin-enriched fraction from ginseng</atitle><jtitle>Journal of ginseng research</jtitle><addtitle>J Ginseng Res</addtitle><date>2019-04-01</date><risdate>2019</risdate><volume>43</volume><issue>2</issue><spage>209</spage><epage>217</epage><pages>209-217</pages><issn>1226-8453</issn><eissn>2093-4947</eissn><abstract>Ginseng is a traditional herbal medicine for human health. Ginseng contains a bioactive ligand named gintonin. The active ingredient of gintonin is lysophosphatidic acid C18:2 (LPA C18:2). We previously developed a method for gintonin-enriched fraction (GEF) preparation to mass-produce gintonin from ginseng. However, previous studies did not show the presence of other bioactive lipids besides LPAs. The aim of this study was to quantify the fatty acids, lysophospholipids (LPLs), and phospholipids (PLs) besides LPAs in GEF.
We prepared GEF from white ginseng. We used gas chromatography-mass spectrometry for fatty acid analysis and liquid chromatography-tandem mass spectrometry for PL analysis, and quantified the fatty acids, LPLs, and PLs in GEF using respective standards. We examined the effect of GEF on insulin secretion in INS-1 cells.
GEF contains about 7.5% linoleic (C18:2), 2.8% palmitic (C16:0), and 1.5% oleic acids (C18:1). GEF contains about 0.2% LPA C18:2, 0.06% LPA C16:0, and 0.02% LPA C18:1. GEF contains 0.08% lysophosphatidylcholine, 0.03% lysophosphatidylethanolamine, and 0.13% lysophosphatidylinositols. GEF also contains about 1% phosphatidic acid (PA) 16:0-18:2, 0.5% PA 18:2-18:2, and 0.2% PA 16:0-18:1. GEF-mediated insulin secretion was not blocked by LPA receptor antagonist.
We determined four characteristics of GEF through lipid analysis and insulin secretion. First, GEF contains a large amount of linoleic acid (C18:2), PA 16:0-18:2, and LPA C18:2 compared with other lipids. Second, the main fatty acid component of LPLs and PLs is linoleic acid (C18:2). Third, GEF stimulates insulin secretion not through LPA receptors. Finally, GEF contains bioactive lipids besides LPAs.</abstract><cop>Korea (South)</cop><pub>Elsevier B.V</pub><pmid>30962735</pmid><doi>10.1016/j.jgr.2017.11.006</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4257-577X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1226-8453 |
ispartof | Journal of Ginseng Research, 2019, 43(2), , pp.209-217 |
issn | 1226-8453 2093-4947 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_4845096 |
source | ScienceDirect (Online service); PubMed Central |
subjects | Ginseng Gintonin Insulin LPA Phosphatidic acid 기타의약학 |
title | Bioactive lipids in gintonin-enriched fraction from ginseng |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A37%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-nurimedia_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioactive%20lipids%20in%20gintonin-enriched%20fraction%20from%20ginseng&rft.jtitle=Journal%20of%20ginseng%20research&rft.au=Cho,%20Hee-Jung&rft.date=2019-04-01&rft.volume=43&rft.issue=2&rft.spage=209&rft.epage=217&rft.pages=209-217&rft.issn=1226-8453&rft.eissn=2093-4947&rft_id=info:doi/10.1016/j.jgr.2017.11.006&rft_dat=%3Cnurimedia_nrf_k%3ENODE08758665%3C/nurimedia_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c581t-4c6558c7806df6160506fb5e0fd5dae71e8dde86ad9eedd4030a3c8332fdf6243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30962735&rft_nurid=NODE08758665&rfr_iscdi=true |